News

The Greater Bay Area International Clinical Trial Institute (GBAICTI) was pleased to participate in the Global Health Summit 2026, joining healthcare leaders, innovators and industry stakeholders from around the world to discuss the future of health and medical innovation.

Our CEO, Professor Bernard Cheung, moderated the panel discussion, "From Unmet Needs to Real Clinical Value: How Biotech Founders Make Decisions and Trade-offs." The discussion examined how biotech companies navigate critical decisions across the innovation journey, from research and development to clinical translation and patient access. Panellists also explored the opportunities and challenges involved in balancing scientific advancement, commercial considerations and real-world patient impact.